This article is more than 5 years old. Information may no longer be current.
Cardiology Today's top articles posted in November
Click Here to Manage Email Alerts
Cardiology Today compiled a list of the top 5 stories posted to Healio.com/Cardiology in November.
This month, Cardiology Today readers were most interested in the new hypertension guidelines; the link between physical activity and CV risk; the future of technology in health care; optimal diets for CV health; the effect of PCSK9 inhibitor therapy in patients with PAD and MI; and much more.
New guidelines broaden definition of hypertension
Hypertension is now defined as systolic BP 130 mm Hg/diastolic BP 80 mm Hg, which will lead to a new diagnosis of hypertension in approximately 14% more Americans, according to long-awaited guidelines from the American Heart Association, American College of Cardiology and nine other societies, presented at the AHA Scientific Sessions.
The guidelines lower the threshold for hypertension from systolic BP 140 mm Hg/diastolic BP 80 mm Hg, and eliminate the category of prehypertension.
Higher physical activity associated with lower CVD risk in Chinese adults
Increased physical activity may reduce the risk for major CVD among Chinese adults, according to a study published in JAMA Cardiology.
The new findings reinforce guidelines that promote any physical activity for CVD prevention, according to the researchers.
Technology and health care: The future is bright
A new era of health care innovation is here, with novel technologies aimed to improve the lives of patients and physicians alike, from mobile technologies to intelligent care.
Since advancements were made during the “communication revolution,” a host of new technologies are evolving every day and improving the daily lives of the average individual. Health care is finally catching up to the rest of the world, with regard to technological advancements, according to experts speaking at the AHA Scientific Sessions during a session devoted to health tech.
Sodium, coconut oil, sugar intake affects CVD risk
Consumption of coconut oil, sodium and added sugars contribute to increased risk for CVD, according to presentations at AHA Scientific Sessions.
Evolocumab effective regardless of PAD, MI status
In two new analyses of the FOURIER trial, treatment with the PCSK9 inhibitor evolocumab (Repatha, Amgen) reduced CV events in various populations, including those with peripheral artery disease and MI.
Researchers said the analyses demonstrate that evolocumab may be appropriate for patients with very high risk.